These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23091107)

  • 1. Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?
    Weinfurt KP; Seils DM; Lin L; Sulmasy DP; Astrow AB; Hurwitz HI; Cohen RB; Meropol NJ
    J Clin Oncol; 2012 Dec; 30(35):4396-400. PubMed ID: 23091107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.
    Weinfurt KP; Seils DM; Tzeng JP; Compton KL; Sulmasy DP; Astrow AB; Solarino NA; Schulman KA; Meropol NJ
    Med Decis Making; 2008; 28(4):575-81. PubMed ID: 18378940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dispositional optimism and therapeutic expectations in early-phase oncology trials.
    Jansen LA; Mahadevan D; Appelbaum PS; Klein WM; Weinstein ND; Mori M; Daffé R; Sulmasy DP
    Cancer; 2016 Apr; 122(8):1238-46. PubMed ID: 26882017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
    Weinfurt KP; Castel LD; Li Y; Sulmasy DP; Balshem AM; Benson AB; Burnett CB; Gaskin DJ; Marshall JL; Slater EF; Schulman KA; Meropol NJ
    Cancer; 2003 Jul; 98(1):166-75. PubMed ID: 12833469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.
    Sulmasy DP; Astrow AB; He MK; Seils DM; Meropol NJ; Micco E; Weinfurt KP
    Cancer; 2010 Aug; 116(15):3702-11. PubMed ID: 20564120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intervention to improve cancer patients' understanding of early-phase clinical trials.
    Kass NE; Sugarman J; Medley AM; Fogarty LA; Taylor HA; Daugherty CK; Emerson MR; Goodman SN; Hlubocky FJ; Hurwitz HI; Carducci M; Goodwin-Landher A
    IRB; 2009; 31(3):1-10. PubMed ID: 19552233
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.
    Nurgat ZA; Craig W; Campbell NC; Bissett JD; Cassidy J; Nicolson MC
    Br J Cancer; 2005 Mar; 92(6):1001-5. PubMed ID: 15770219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three randomized controlled trials evaluating the impact of "spin" in health news stories reporting studies of pharmacologic treatments on patients'/caregivers' interpretation of treatment benefit.
    Boutron I; Haneef R; Yavchitz A; Baron G; Novack J; Oransky I; Schwitzer G; Ravaud P
    BMC Med; 2019 Jun; 17(1):105. PubMed ID: 31159786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception.
    Weinfurt KP; Sulmasy DP; Schulman KA; Meropol NJ
    Theor Med Bioeth; 2003; 24(4):329-44. PubMed ID: 14620488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of quality of life on patient expectations regarding phase I clinical trials.
    Cheng JD; Hitt J; Koczwara B; Schulman KA; Burnett CB; Gaskin DJ; Rowland JH; Meropol NJ
    J Clin Oncol; 2000 Jan; 18(2):421-8. PubMed ID: 10637258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expectations and experiences of patients with cancer participating in phase I clinical trials.
    Yoder LH; O'Rourke TJ; Etnyre A; Spears DT; Brown TD
    Oncol Nurs Forum; 1997 Jun; 24(5):891-6. PubMed ID: 9201741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?
    Miller FG; Joffe S
    Clin Trials; 2008; 5(6):617-23. PubMed ID: 19029210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?
    Hlubocky FJ; Sachs GA; Larson ER; Nimeiri HS; Cella D; Wroblewski KE; Ratain MJ; Peppercorn JM; Daugherty CK
    J Clin Oncol; 2018 Aug; 36(24):2483-2491. PubMed ID: 29985748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials.
    Reeder-Hayes KE; Roberts MC; Henderson GE; Dees EC
    J Oncol Pract; 2017 Oct; 13(10):e863-e873. PubMed ID: 28837373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons given by patients for participating, or not, in Phase 1 cancer trials.
    Catt S; Langridge C; Fallowfield L; Talbot DC; Jenkins V
    Eur J Cancer; 2011 Jul; 47(10):1490-7. PubMed ID: 21454072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative assessment of the experience of participating in a cancer-related clinical trial.
    Wootten AC; Abbott JM; Siddons HM; Rosenthal MA; Costello AJ
    Support Care Cancer; 2011 Jan; 19(1):49-55. PubMed ID: 19960208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials.
    Aaronson NK; Visser-Pol E; Leenhouts GH; Muller MJ; van der Schot AC; van Dam FS; Keus RB; Koning CC; ten Bokkel Huinink WW; van Dongen JA; Dubbelman R
    J Clin Oncol; 1996 Mar; 14(3):984-96. PubMed ID: 8622050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing cancer clinical trial management: recommendations from a qualitative study of trial participants' experiences.
    Cox K
    Psychooncology; 2000; 9(4):314-22. PubMed ID: 10960929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communication about the risks and benefits of phase I pediatric oncology trials.
    Hazen RA; Zyzanski S; Baker JN; Drotar D; Kodish E
    Contemp Clin Trials; 2015 Mar; 41():139-45. PubMed ID: 25638751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group.
    Estlin EJ; Cotterill S; Pratt CB; Pearson AD; Bernstein M
    J Clin Oncol; 2000 May; 18(9):1900-5. PubMed ID: 10784630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.